There are 2789 resources available
Discussion 4MO, 5MO and 6MO
Presenter: Ruth Plummer
Session: Mini oral session - Basic science
Resources:
Slides
Webcast
Discussion LBA49, 1192MO and 1193MO
Presenter: Sai-Hong Ou
Session: Mini oral session - NSCLC, metastatic
Resources:
Slides
Webcast
Discussion 725MO and 726MO
Presenter: David SP Tan
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast
Discussion LBA34 and 795MO
Presenter: Naveena Singh
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast
579MO - CheckMate 9KD cohort A2 final analysis: Nivolumab (NIVO) + rucaparib for chemotherapy (CT)-naïve metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Daniel Petrylak
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Yes
Presenter: Denis Soulieres
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
No
Presenter: Paolo Bossi
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Q&A
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast